Jennifer L.Del Medico

Partner

(T) + 1.212.326.3658

Jennifer Del Medico defends clients in mass tort and class action litigations focusing on alleged violations of consumer protection laws, property damage, and environmental torts. She has defended alleged violations of the New Jersey Consumer Fraud Act for clients in a wide range of industries, including automotive parts, personal care products, baby products, and credit reporting. She also has litigated cases involving complex financial products, collateralized debt obligations, and securities claims. She was part of the team representing Lehman Brothers Holdings and its affiliated debtors at trial in the first derivatives cases in the Lehman bankruptcy.

Jennifer's practice also includes defending pharmaceutical and health care companies in False Claims Act matters, as well as in government investigations of allegations related to kickbacks and off-label marketing. She defended Celgene Corporation in connection with an FCA lawsuit alleging that Celgene promoted two of its cancer treatments for off-label uses and that Celgene paid kickbacks to physicians to get them to promote or prescribe the treatments.

Jennifer has extensive experience planning, implementing, and managing electronic discovery projects in the U.S. and abroad relating to potential and active litigations. She has been responsible for managing large teams of lawyers in executing major discovery projects on time and within budget.

Jennifer maintains an active pro bono practice representing clients in immigration court and in conjunction with applications to the United States Citizenship and Immigration Services.

Experience

News media defeats web pundit Facebook conspiracy claim
Jones Day represented CNN, NPR, PBS, and NewsHour Productions LLC in obtaining a dismissal of a web pundit plaintiff's claim that the media companies conspired with Facebook to prevent the plaintiff's media company from making effective use of the social media platform.

Kipling, Nautica, and Timberland win permanent injunction and $31 million damage award in counterfeit action
Kipling Apparel Corp., Nautica Apparel, Inc., and TBL Licensing LLC (Timberland) won a default judgment and permanent injunction, in an action to combat the unauthorized and counterfeit uses of the three plaintiffs' famous trademarks in multiple domain names and copycat websites.

Celgene resolves False Claims Act case related to alleged off-label promotion of Thalomid® and Revlimid®
Jones Day represented Celgene Corporation in a False Claims Act lawsuit related to allegations that Celgene promoted the cancer treatment drugs Thalomid® and Revlimid® for off-label uses prior to their FDA approval for such uses, and paid kickbacks to physicians in order to get them to promote and prescribe those drugs.

Goodman defeats class certification in putative consumer class actions alleging sale of failure-prone air conditioner components
Jones Day represents Goodman Global, Inc. and its affiliates, the manufacturers of central air conditioning and heating systems sold under the Goodman, Amana, and Daikin brands, in a series of putative consumer class actions.

U.S. company evaluates issues associated with filing an antidumping or countervailing duty petition
Jones Day is helping a U.S. company evaluate issues associated with filing an antidumping and/or countervailing duty petition targeting products imported from China.

LabCorp obtains dismissal of qui tam action alleging violations of Anti-Kickback Statute and Medicare billing regulation
On behalf of Laboratory Corporation of America (LabCorp), a nationwide provider of health care diagnostic testing services, Jones Day successfully moved to dismiss a qui tam complaint filed in the U.S. District Court for the Southern District of New York under the federal False Claims Act (FCA) and the FCA analogs in 14 states and the District of Columbia.

IBM resolves claims related to alleged exposure to toxic emissions
Jones Day client International Business Machines Corporation (IBM) resolved numerous claims brought by hundreds of current and former residents of Endicott, NY alleging personal injuries, diminution in property values, and other damages related to alleged vapor intrusion and historic air emissions in the area from IBM's former manufacturing facility.

Essilor acquires controlling stake in Transitions Optical joint venture with PPG for $1.7 billion
Jones Day advised Essilor International SA in its $1.7 billion buyout of a 51 percent interest in Transitions Optical group from joint venture partner PPG Industries.

Procter & Gamble resolves nationwide class actions related to marketing for Crest Sensitivity & Protection Toothpaste
Jones Day represented The Procter & Gamble Company in connection with a number of nationwide class actions alleging consumer fraud related to the marketing and distribution of Crest Sensitivity & Protection Toothpaste.

Lehman Brothers Holdings seeks recovery of undisclosed asset value transferred in bankruptcy sale of broker dealer
Jones Day represents Lehman Brothers Holdings Inc. in an action to recover assets transferred to Barclays Capital Inc. when Barclays purchased the Lehman broker dealer business shortly after Lehman's bankruptcy filing in September 2008.

RBS Citizens prevails at bench trial in trademark infringement case
Jones Day successfully represented RBS Citizens at a preliminary injunction hearing and subsequent bench trial in a trademark infringement case.

Mitsubishi pursues injunctive relief in N.Y. Supreme Court in international multi-million dollar letter-of-credit dispute
Jones Day represented Mitsubishi Corporation in a time-sensitive New York Supreme Court proceeding for a temporary restraining order and preliminary injunctive relief involving a multi-million dollar, international, letter-of-credit dispute.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.